Actively Recruiting
BostonGene-Integrated Genomic Registry (BIGR)
Led by BostonGene · Updated on 2024-02-07
100000
Participants Needed
1
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types
CONDITIONS
Official Title
BostonGene-Integrated Genomic Registry (BIGR)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suspected or confirmed malignancy
- Planned comprehensive genomic (> 100 genes) and/or molecular analysis; or genomic and/or molecular data available from prior sequencing
- Baseline demographics and treatment information available
- Willingness for future contact by BIRG study personnel to provide information regarding associated cancer outcomes and treatment
- Signed informed consent to participate in the study
- Living in the United States at the time of enrollment
You will not qualify if you...
- Life expectancy less than 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
BostonGene
Waltham, Massachusetts, United States, 02453
Actively Recruiting
Research Team
N
Nathan Fowler
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here